Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021

SELL
$15.73 - $21.66 $373,744 - $514,641
-23,760 Closed
0 $0
Q3 2020

Nov 06, 2020

BUY
$13.54 - $26.41 $321,710 - $627,501
23,760 New
23,760 $403,000
Q2 2020

Aug 10, 2020

SELL
$7.84 - $23.29 $167,509 - $497,614
-21,366 Closed
0 $0
Q1 2020

May 08, 2020

BUY
$5.57 - $11.5 $93,698 - $193,453
16,822 Added 370.2%
21,366 $179,000
Q4 2019

Feb 04, 2020

BUY
$7.9 - $10.14 $35,897 - $46,076
4,544 New
4,544 $44,000

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Aigen Investment Management, LP Portfolio

Follow Aigen Investment Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Aigen Investment Management, LP with notifications on news.